Cardinal Health Inc (CAH) is slightly overvalued and Henry Schein Inc (HSIC) is overvalued.
Both trade above our estimate of their intrinsic value. CAH is the closer of the two: -9%, against -48% for HSIC.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $203.47; the price of $222.04 is 9% above that value, and 80% of that value comes from beyond year five.
Leak Score 43/100 on 8 of 12 signals
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $58.94; the price of $87.43 is 48% above that value, and 79% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
| Metric | CAH | HSIC |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $222.04 | $87.43 |
| Intrinsic value | $203.47 | $58.94 |
| Margin of safety | -9% | -48% |
| Leak Score | 43/100 (8/12) | 14/100 (3/12) |
| Market cap | $51.6B | $9.7B |
| Revenue growth, 5 years | 9.4% | 5.4% |
| Operating margin | 1.3% | 6.0% |
| Net margin | 0.7% | 3.0% |
| Return on equity | — | 12.2% |
| Debt to equity | — | 1.21 |
| P/E | 30.7x | 25.5x |
| Forward P/E | 15.8x | 14.6x |
| P/B | — | 3.1x |
| Dividend yield | 0.9% | — |